Lee, Ming-ChiaMing-ChiaLeeFujita, YuitoYuitoFujitaMuraki, ShotaShotaMurakiHuang, Hung-LingHung-LingHuangLee, Chih-HsinChih-HsinLeeJANN-YUAN WANGIeiri, IchiroIchiroIeiri2022-12-202022-12-2020230306-5251https://scholars.lib.ntu.edu.tw/handle/123456789/626640A population pharmacokinetic (PPK) study of the correlation of adverse drug reactions (ADRs) with the 3HP regimen (weekly high-dose rifapentine plus isoniazid for 12 doses) for latent tuberculosis infection (LTBI) remains lacking. The purpose of this study is to determine the association of rifapentine or isoniazid concentration and ADRs.enflu-like symptoms; isoniazid; population pharmacokinetics; rifapentine; tuberculosis preventive therapy[SDGs]SDG3Isoniazid level and flu-like symptoms during rifapentine-based tuberculosis preventive therapy: A population pharmacokinetic analysisjournal article10.1111/bcp.15527361009602-s2.0-85138742693WOS:000860297800001https://api.elsevier.com/content/abstract/scopus_id/85138742693